<DOC>
	<DOCNO>NCT00162318</DOCNO>
	<brief_summary>The purpose study find safe effective dose Erbitux Iressa subject non small cell lung cancer .</brief_summary>
	<brief_title>A Phase I Study Cetuximab Combination With Gefitinib Patients With Advanced/Metastatic Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Subjects advance metastatic non small cell lung cancer . Subjects least one prior chemotherapy platinum base therapy . Subjects exclude study non small cell lung cancer advance metastatic least one prior platinum base chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>